Novo Nordisk
NVO
$122.71
Share price
-0.03%
Change (1 day)
48.72%
Change (1 year)
Categories
Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
Novo Nordisk (NVO) - Net assets
Net assets on the balance sheet as of December 2023 : $15.78 B
According to Novo Nordisk's latest financial reports the company has $15.78 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Novo Nordisk - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $15.78 B | 31.27% |
| 2022-12-31 | $12.02 B | 11.62% |
| 2021-12-31 | $10.77 B | 2.9% |
| 2020-12-31 | $10.46 B | 21.22% |
| 2019-12-31 | $8.63 B | 8.72% |
| 2018-12-31 | $7.94 B | -1.1% |
| 2017-12-31 | $8.03 B | 25.29% |
| 2016-12-31 | $6.40 B | -6.88% |
| 2015-12-31 | $6.88 B | 4.59% |
| 2014-12-31 | $6.58 B | -16.5% |
| 2013-12-31 | $7.88 B | 9.39% |
| 2012-12-31 | $7.20 B | 10.44% |
| 2011-12-31 | $6.52 B | -1.11% |
| 2010-12-31 | $6.59 B | -4.16% |
| 2009-12-31 | $6.88 B | 10.89% |
| 2008-12-31 | $6.20 B | -1.56% |
| 2007-12-31 | $6.30 B | 18.04% |
| 2006-12-31 | $5.34 B | 22.28% |
| 2005-12-31 | $4.36 B | -10.07% |
| 2004-12-31 | $4.85 B | 13.56% |
| 2003-12-31 | $4.27 B | 30.8% |
| 2002-12-31 | $3.27 B | 14.01% |
| 2001-12-31 | $2.86 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $89.28 B | 465.76% | 🇺🇸 USA |
 Eli Lilly LLY | $10.86 B | -31.16% | 🇺🇸 USA |
 Sanofi SNY | $82.20 B | 420.87% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $29.48 B | 86.83% | 🇺🇸 USA |